Exosomes Market Overview
Exosomes Market was valued at US$ 191.1 million in 2024 and is projected to grow at a CAGR of 4.40% to reach US$ 3328.2 million by 2034.
Exosomes are cell-derived and the minor type of extracellular vesicles of endosomal origin, enveloped with the lipid bilayer. Exosomes play an essential role in cell biology and, thus, represent a novel model of cell communication.
A wide variety of applications of exosomes and technological innovation in exosome isolation have provided lucrative opportunities for market growth. The rising prevalence of cancer diseases and government spending on exosome research is further expected to favor exosome market growth in coming years.
Exosomes Market Dynamics
Rising prevalence of cancer diseases due to unhealthy lifestyle, poor nutrition food, lack of exercise has given positive impact on Exosomes market growth. Wide variety of applications in various diseases has favored market growth.
According to PMC (PubMed Central), in 2018, exosome-based drug delivery strategies in clinical and preclinical showed dramatically decrease in development of cancer and function as cell free vaccines by providing alternative strategies for exosome-based anticancer therapies in cancer treatment which, in turn is likely to provide lucrative opportunities in Exosomes market growth.
For instance, in 2019, according to CDC (Centers for Disease Control and Prevention), around 1,752,735 new cancer cases were reported and 599,589 people were died of cancer in United States. Thus, growing prevalence of cancer diseases has foster the demand for Exosomes market growth.
Restrains:
However, several challenges to face by scientist in exosome manufacturing, research & development activity due to mistakes done by researchers has restrains market growth. Lack of gold standard procedures for exosome production has hampered Exosomes market growth.
Exosomes Market Segmentation
Exosomes Market is segmented based on Product, Workflow, Application, End-Users and Region.
Product Insight
On the basis of Product, Exosomes Market is segmented into Instruments, Kits & Reagents, Services. Kits & Reagents product segment is expected to dominate the target market growth. Kits & Reagents are further divided into isolation, purification, antibodies, quantitation kits & reagents which has driven product segment.
Workflow Insights
On the basis of Workflow, Exosomes Market is segmented into Downstream Analysis, Isolation Methods. Downstream Analysis workflow segment is expected to dominate the target market growth due to advancement in product for downstream analysis and presence of major key players in offering various technologically innovative products in analysis.
Application Insights
On the basis of Application, Exosomes Market is segmented into Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others. Cancer application segment is expected to dominate the target market growth due to growing demand of exosomes research in lung cancer management.
End-Users Insights
On the basis of End-Users, Exosomes Market is segmented into Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others. Academic & Research Institutes segment is expected to dominate the target market growth due to growing demand for exosome research from past few years due to potential applications in diagnosis of disease.
Regional Insights:
On region the Exosomes Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period. Moreover, rising prevalence of cancer disease, unhealthy diet, sedentary lifestyle, high disposable income, growing research & development activities in exosomes, government initiative and funding in exosome research, technological advancement and well advanced research institutes, is anticipated to increase demand for Exosomes in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product - Instruments, Kits & Reagents, Services By Workflow - Downstream Analysis, Isolation Methods By Application - Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others By End-Users - Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Exosomes Market report based on Product, Workflow, Application, End-Users and Region.
Exosomes Market, By Product:
- Instruments
- Kits & Reagents
- Services
Exosomes Market, By Workflow:
- Downstream Analysis
- RNA analysis with PCR and NGS
- Protein analysis using blotting & ELISA
- Cell surface marker analysis using flow cytometry
- Proteomic analysis using mass spectroscopy
- Others
- Isolation Methods
- Precipitation
- Ultracentrifugation
- Filtration
- Immunocapture on beads
- Others
Exosomes Market, By Application:
- Infectious Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Cancer
- Others
Exosomes Market, By End-Users:
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Pharmaceutical Companies
- Others
Exosomes Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Exosomes Market Key Players
The key players operating the Exosomes Market includes, Hologic Inc., Bio-Techne Corp., Danaher Corp., Lonza, Fujifilm Holdings Corp., Thermo Fisher Scientific Inc., QIAGEN, RoosterBio Inc., Miltenyi Biotec, Abcam plc., and others.
Exosomes Market Key Issues Addressed
Recent Development:
- In February 2021, Evox Therapeutics has set in developing treatments for inborn errors of metabolism. The company has raised around $95.4 million from GV and OrbiMed to advance pipeline of Exosome-based treatments in clinic.
Exosomes Market Company Profile
- Hologic Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Techne Corp.
- Danaher Corp.
- Lonza
- Fujifilm Holdings Corp.
- Thermo Fisher Scientific Inc.
- QIAGEN
- RoosterBio Inc.
- Miltenyi Biotec
- Abcam plc
“*” marked represents similar segmentation in other categories in the respective section
Exosomes Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Workflow
- Market Snippet, By Application
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Kits & Reagents
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Services
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By Workflow, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Downstream Analysis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Isolation Methods
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Infectious Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cardiovascular Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Neurodegenerative Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cancer
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Academic & Research Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Pharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Workflow, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Workflow, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Workflow, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Overview
-
- Latin America
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Workflow, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Latin America
-
-
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Workflow, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
-
-
-
-
- GCC
- Israel
- South Africa
- Rest of Middle East
-
-
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Hologic Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Techne Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lonza
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fujifilm Holdings Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- QIAGEN
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- RoosterBio Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Miltenyi Biotec
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abcam plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Exosomes Market is segmented into Product, Workflow, Application, End-Users and Region.
Exosomes Market is driven by factors like growing prevalence of cancer diseases.
By region, the Exosomes market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Exosomes Market includes, Hologic Inc., Bio-Techne Corp., Danaher Corp., Lonza, Fujifilm Holdings Corp., Thermo Fisher Scientific Inc., QIAGEN, RoosterBio Inc., Miltenyi Biotec, Abcam plc., and others.
Exosomes Market accounted for US$ 112.25 Million in 2022 and is estimated to be US$ 1,955.3 Million by 2032 and is anticipated to register a CAGR of 31.1%.